Serina Therapeutics, Inc. (SER)

Serina Therapeutics Statistics

Total Valuation

SER has a market cap or net worth of $51.97 million. The enterprise value is $45.68 million.

Market Cap	51.97M
Enterprise Value	45.68M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, after market close.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

SER has 10.25 million shares outstanding. The number of shares has increased by 138.29% in one year.

Current Share Class	10.25M
Shares Outstanding	10.25M
Shares Change (YoY)	+138.29%
Shares Change (QoQ)	+2.54%
Owned by Insiders (%)	29.25%
Owned by Institutions (%)	6.31%
Float	3.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	395.04
Forward PS	n/a
PB Ratio	31.20
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	351.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.22.

Current Ratio	2.24
Quick Ratio	1.70
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-495.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-132.37%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-386.77%
Revenue Per Employee	$10,000
Profits Per Employee	-$977,538
Employee Count	13
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.27%
50-Day Moving Average	5.36
200-Day Moving Average	5.26
Relative Strength Index (RSI)	44.91
Average Volume (20 Days)	337,853

Short Selling Information

The latest short interest is 214,808, so 2.10% of the outstanding shares have been sold short.

Short Interest	214,808
Short Previous Month	51,313
Short % of Shares Out	2.10%
Short % of Float	6.98%
Short Ratio (days to cover)	0.78

Income Statement

In the last 12 months, SER had revenue of $130,000 and -$12.71 million in losses. Loss per share was -$1.34.

Revenue	130,000
Gross Profit	-10.75M
Operating Income	-20.81M
Pretax Income	-890,146
Net Income	-12.71M
EBITDA	-20.66M
EBIT	-20.81M
Loss Per Share	-$1.34

Balance Sheet

The company has $6.04 million in cash and $362,000 in debt, giving a net cash position of $5.68 million or $0.55 per share.

Cash & Cash Equivalents	6.04M
Total Debt	362,000
Net Cash	5.68M
Net Cash Per Share	$0.55
Equity (Book Value)	1.65M
Book Value Per Share	-0.31
Working Capital	4.43M

Cash Flow

In the last 12 months, operating cash flow was -$15.62 million and capital expenditures -$54,000, giving a free cash flow of -$15.68 million.

Operating Cash Flow	-15.62M
Capital Expenditures	-54,000
Free Cash Flow	-15.68M
FCF Per Share	-$1.53

Margins

Gross Margin	n/a
Operating Margin	-16,006.15%
Pretax Margin	-9,733.08%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-138.29%
Shareholder Yield	-138.29%
Earnings Yield	-24.75%
FCF Yield	-30.53%

Analyst Forecast

The average price target for SER is $13.00, which is 156.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	156.41%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SER has an Altman Z-Score of -11.11 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.11
Piotroski F-Score	1